The quarter beat a market baseline that was already elevated. Revenue of $1.004 billion exceeded the published consensus of approximately $962 million, while non-GAAP EPS of $0.99 topped the roughly $0.92 expectation. That is a meaningful upside surprise, not merely a record result against an easy comparison.
| Metric | Q2 2026 | Q2 2025 | Published expectation |
|---|---|---|---|
| Revenue | $1,004.1 million (Consolidated Statements of Operations) | $730.6 million (Consolidated Statements of Operations) | ~$962.0 million |
| Non-GAAP EPS | $0.99 (Non-GAAP net income and EPS reconciliation) | $0.58 (Non-GAAP net income and EPS reconciliation) | ~$0.92 |
| Adjusted EBITDA | $166.8 million (Adjusted EBITDA reconciliation) | $109.7 million (Adjusted EBITDA reconciliation) | Not available |
| Adjusted EBITDA margin | 16.6% (Adjusted EBITDA reconciliation) | 15.0% (Adjusted EBITDA reconciliation) | Not available |
| Operating cash flow | $96.4 million (Free cash flow reconciliation) | $97.8 million (Free cash flow reconciliation) | Not available |
| Free cash flow | $46.0 million (Free cash flow reconciliation) | $37.6 million (Free cash flow reconciliation) | Not available |
The upside came primarily from Data Center and Networking, not broad-based acceleration alone. That market reached 40% of sales and grew 91% year over year, helping drive total revenue growth of 37%; Medical, Industrial and Instrumentation also grew 33%, while Aerospace and Defense rose 14% (Supplemental Data; Management commentary). The 1.49 total book-to-bill and more than $1.7 billion of program backlog add forward visibility, although the mix is increasingly dependent on AI-related demand.
Profitability improved beyond the revenue beat. Adjusted EBITDA margin expanded to 16.6% from 15.0%, and GAAP operating margin rose to 10.9% from 8.5% (Supplemental Data; Adjusted EBITDA reconciliation). That supports the company's claim that operating leverage is emerging, but the headline non-GAAP EPS should be read with some caution: adjustments excluded stock compensation, amortization, restructuring and acquisition costs, as well as a $14.0 million unrealized derivative loss (Non-GAAP net income and EPS reconciliation).
The outlook is the clearest incremental positive. Third-quarter guidance of $1.10 billion to $1.14 billion in revenue and $1.21 to $1.27 of non-GAAP EPS implies another step up from Q2, while full-year guidance now calls for approximately $4.4 billion of revenue and EPS approaching $5.00 (Business Outlook). The guidance excludes any contribution from the pending European acquisitions, so the underlying target is based on existing operations rather than assumed deal synergies.
The main offset is cash intensity, not demand. Second-quarter free cash flow was positive at $46.0 million, but first-half free cash flow remained negative at $39.0 million because capital expenditures reached $157.2 million (Free cash flow reconciliation). TTM also expanded financing capacity through a $1.0 billion revolver and a larger Term Loan B, which improves flexibility for acquisitions but signals that the European expansion will add execution and balance-sheet considerations (Management commentary). Net versus expectations, the filing is clearly better than anticipated: a revenue and EPS beat reinforced by stronger margins and higher guidance, with cash investment and non-GAAP adjustments as the principal qualifications.
Read the original 8-K on SEC EDGAR ↗